{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:56:00Z","timestamp":1771955760258,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s10815-020-01742-5","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T01:01:11Z","timestamp":1584493271000},"page":"1163-1170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A prospective randomized trial comparing corifollitropin-\u03b1 late-start (day 4) versus standard administration (day 2) in expected poor, normal, and high responders undergoing controlled ovarian stimulation for IVF"],"prefix":"10.1007","volume":"37","author":[{"given":"Alberto","family":"Revelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Gennarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Sestero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Canosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Carosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Salvagno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Pittatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Filippini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Benedetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"issue":"10","key":"1742_CR1","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1073\/pnas.89.10.4304","volume":"89","author":"FA Fares","year":"1992","unstructured":"Fares FA, Suganuma N, Nishimori K, LaPolt PS, Hsueh AJ, Boime I. Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit. Proc Natl Acad Sci U S A. 1992;89(10):4304\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1742_CR2","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1210\/endo.131.6.1446593","volume":"131","author":"PS LaPolt","year":"1992","unstructured":"LaPolt PS, Nishimori K, Fares FA, Perlas E, Boime I, Hsueh AJ. Enhanced stimulation of follicle maturation and ovulatory potential by long acting follicle-stimulating hormone agonists with extended carboxyl-terminal peptides. Endocrinology. 1992;131(6):2514\u201320.","journal-title":"Endocrinology"},{"issue":"3","key":"1742_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/humupd\/dmn065","volume":"15","author":"BCJM Fauser","year":"2009","unstructured":"Fauser BCJM, Mannaerts BMJL, Devroey P, Leader A, Boime I, Baird DT. Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency. Hum Reprod Update. 2009;15(3):309\u201321.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"1742_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10815-014-0426-6","volume":"32","author":"A Revelli","year":"2015","unstructured":"Revelli A, Pittatore G, Casano S, Canosa S, Evangelista F, Benedetto C. Efficacy and safety of late-start Corifollitropin-alfa administration for controlled ovarian hyperstimulation in IVF: a cohort, case-control study. J Assist Reprod Genet. 2015;32(3):429\u201334.","journal-title":"J Assist Reprod Genet"},{"issue":"12","key":"1742_CR5","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1093\/humrep\/dep340","volume":"24","author":"M Brandes","year":"2009","unstructured":"Brandes M, van der Steen JOM, Bokdam SB, Hamilton CJCM, de Bruin JP, Nelen WLDM, et al. When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility population. Hum Reprod. 2009;24(12):3127\u201335.","journal-title":"Hum Reprod"},{"issue":"5","key":"1742_CR6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S1472-6483(10)61043-7","volume":"14","author":"G Nargund","year":"2007","unstructured":"Nargund G, Frydman R. Towards a more physiological approach to IVF. Reprod BioMed Online. 2007;14(5):550\u20132.","journal-title":"Reprod BioMed Online"},{"issue":"1","key":"1742_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/humupd\/dmn056","volume":"15","author":"MFG Verberg","year":"2009","unstructured":"Verberg MFG, Macklon NS, Nargund G, Frydman R, Devroey P, Broekmans FJ, et al. Mild ovarian stimulation for IVF. Hum Reprod Update. 2009;15(1):13\u201329.","journal-title":"Hum Reprod Update"},{"issue":"9563","key":"1742_CR8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(07)60360-2","volume":"369","author":"EM Heijnen","year":"2007","unstructured":"Heijnen EM, Eijkemans MJ, De Klerk C, Polinder S, Beckers NG, Klinkert ER, et al. A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet. 2007;369(9563):743\u20139.","journal-title":"Lancet"},{"issue":"7","key":"1742_CR9","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/humrep\/deu105","volume":"29","author":"C Blockeel","year":"2014","unstructured":"Blockeel C, Polyzos NP, Derksen L, De Brucker M, Vloeberghs V, van de Vijver A, et al. Administration of corifollitropin alfa on day 2 versus day 4 of the cycle in a GnRH antagonist protocol: a randomized controlled pilot study. Hum Reprod. 2014;29(7):1500\u20137.","journal-title":"Hum Reprod"},{"issue":"10","key":"1742_CR10","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s10815-012-9840-9","volume":"29","author":"E Molinari","year":"2012","unstructured":"Molinari E, Evangelista F, Racca C, Cagnazzo C, Revelli A. Polarized light microscopy-detectable structures of human oocytes and embryos are related to the likelihood of conception in IVF. J Assist Reprod Genet. 2012;29(10):1117\u201322.","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"1742_CR11","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/humrep\/del403","volume":"22","author":"J Holte","year":"2007","unstructured":"Holte J, Berglund L, Milton K, Garello C, Gennarelli G, Revelli A, et al. Construction of an evidence-based integrated morphology cleavage embryo score for implantation potential of embryos scored and transferred on day 2 after oocyte retrieval. Hum Reprod. 2007;22(2):548\u201357.","journal-title":"Hum Reprod"},{"issue":"6","key":"1742_CR12","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/humrep\/der037","volume":"26","author":"Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology","year":"2011","unstructured":"Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod. 2011;26(6):1270\u201383.","journal-title":"Hum Reprod"},{"issue":"3","key":"1742_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/uog.15899","volume":"48","author":"A Revelli","year":"2016","unstructured":"Revelli A, Rovei V, Dalmasso P, Gennarelli G, Racca C, Evangelista F, et al. Large randomized trial comparing transabdominal ultrasound-guided embryo transfer with a technique based on uterine length measurement before embryo transfer. Ultrasound Obstet Gynecol. 2016 Sep;48(3):289\u201395.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"1742_CR14","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.fertnstert.2018.11.047","volume":"111","author":"M Cozzolino","year":"2019","unstructured":"Cozzolino M, Vitagliano A, Cecchino GN, Ambrosini G, Garcia-Velasco JA. Corifollitropin alfa for ovarian stimulation in in vitro fertilization: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2019;111(4):722\u201333.","journal-title":"Fertil Steril"},{"key":"1742_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13048-015-0160-4","volume":"8","author":"S Fensore","year":"2015","unstructured":"Fensore S, Di Marzio M, Tiboni GM. Corifollitropin alfa compared to daily FSH in controlled ovarian stimulation for in vitro fertilization: a meta-analysis. J Ovarian Res. 2015;8:33.","journal-title":"J Ovarian Res"},{"issue":"5","key":"1742_CR16","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1093\/humrep\/det045","volume":"28","author":"NP Polyzos","year":"2013","unstructured":"Polyzos NP, De Vos M, Corona R, Vloeberghs V, Ortega-Hrepich C, Stoop D, et al. Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study. Hum Reprod. 2013;28(5):1254\u201360.","journal-title":"Hum Reprod"},{"key":"1742_CR17","doi-asserted-by":"crossref","unstructured":"Andrisani A, Marin L, Ragazzi E, Don\u00e0 G, Bordin L, Dessole F, et al. Is corifollitropin alfa effective in controlled ovarian stimulation among all poor ovarian responders? A retrospective comparative study. Gynecol Endocrinol. 2019:1\u20135.","DOI":"10.1080\/09513590.2019.1613360"},{"issue":"8","key":"1742_CR18","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s10815-016-0721-5","volume":"33","author":"CE Boots","year":"2016","unstructured":"Boots CE, Meister M, Cooper AR, Hardi A, Jungheim ES. Ovarian stimulation in the luteal phase: systematic review and meta-analysis. J Assist Reprod Genet. 2016;33(8):971\u201380.","journal-title":"J Assist Reprod Genet"},{"issue":"9","key":"1742_CR19","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1093\/humrep\/dei069","volume":"20","author":"EM Kolibianakis","year":"2005","unstructured":"Kolibianakis EM, Bourgain C, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC, et al. Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles. Hum Reprod. 2005;20(9):2453\u20136.","journal-title":"Hum Reprod"},{"issue":"8","key":"1742_CR20","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1093\/humrep\/deq125","volume":"25","author":"E Bosch","year":"2010","unstructured":"Bosch E, Labarta E, Crespo J, Sim\u00f3n C, Remoh\u00ed J, Jenkins J, et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod. 2010;25(8):2092\u2013100.","journal-title":"Hum Reprod"},{"issue":"5","key":"1742_CR21","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.rbmo.2010.06.032","volume":"21","author":"BCJM Fauser","year":"2010","unstructured":"Fauser BCJM, Alper MM, Ledger W, Schoolcraft WB, Zandvliet A, Mannaerts BMJL, et al. Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF. Reprod BioMed Online. 2010;21(5):593\u2013601.","journal-title":"Reprod BioMed Online"},{"issue":"11","key":"1742_CR22","doi-asserted-by":"publisher","first-page":"e0206111","DOI":"10.1371\/journal.pone.0206111","volume":"13","author":"T-H Lee","year":"2018","unstructured":"Lee T-H, Tzeng S-L, Lee C-I, Chen H-H, Huang C-C, Chen S-U, et al. Association of progesterone production with serum anti-M\u00fcllerian hormone levels in assisted reproductive technology cycles with corifollitropin alfa. PLoS One. 2018;13(11):e0206111.","journal-title":"PLoS One"},{"issue":"12","key":"1742_CR23","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1093\/humrep\/dep291","volume":"24","author":"P Devroey","year":"2009","unstructured":"Devroey P, Boostanfar R, Koper NP, Mannaerts BMJL, Ijzerman-Boon PC, Fauser BCJM, et al. A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol. Hum Reprod. 2009;24(12):3063\u201372.","journal-title":"Hum Reprod"},{"issue":"1","key":"1742_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.rbmo.2010.03.019","volume":"21","author":"Corifollitropin alfa Ensure Study Group","year":"2010","unstructured":"Corifollitropin alfa Ensure Study Group. Corifollitropin alfa for ovarian stimulation in IVF: a randomized trial in lower-body-weight women. Reprod BioMed Online. 2010;21(1):66\u201376.","journal-title":"Reprod BioMed Online"}],"updated-by":[{"DOI":"10.1007\/s10815-020-01823-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000}}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-020-01742-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10815-020-01742-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-020-01742-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T20:13:19Z","timestamp":1616011999000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10815-020-01742-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1742"],"URL":"https:\/\/doi.org\/10.1007\/s10815-020-01742-5","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10815-020-01823-5","asserted-by":"object"}]},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,18]]},"assertion":[{"value":"19 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article unfortunately has a missing acknowledgement.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval of the study protocol was obtained by the local ethical committee, and informed consent was obtained by all recruited patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}